scholarly journals A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

2018 ◽  
Vol 11 (1) ◽  
Author(s):  
Wan-Hong Zhao ◽  
Jie Liu ◽  
Bai-Yan Wang ◽  
Yin-Xia Chen ◽  
Xing-Mei Cao ◽  
...  
2013 ◽  
Vol 19 (8) ◽  
pp. 2048-2060 ◽  
Author(s):  
Robert O. Carpenter ◽  
Moses O. Evbuomwan ◽  
Stefania Pittaluga ◽  
Jeremy J. Rose ◽  
Mark Raffeld ◽  
...  

2019 ◽  
Vol 10 ◽  
Author(s):  
Marijke Timmers ◽  
Gils Roex ◽  
Yuedi Wang ◽  
Diana Campillo-Davo ◽  
Viggo F. I. Van Tendeloo ◽  
...  

2021 ◽  
Vol 27 (3) ◽  
pp. S433-S434
Author(s):  
Hermann Einsele ◽  
Niels W.C.J. van de Donk ◽  
Bertrand Arnulf ◽  
Jordan M. Schecter ◽  
Kevin C. De Braganca ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document